Kringle Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Kiichi Adachi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8yrs |
| CEO ownership | 1.1% |
| Management average tenure | 2yrs |
| Board average tenure | 6yrs |
CEO
Kiichi Adachi (57 yo)
8yrs
Tenure
Kiichi Adachi, Ph D., has been President at Kringle Pharma, Inc since December 27, 2016. Kiichi Adachi serves as a Director of Kringle Pharma, Inc. since December 2005.Kiichi Adachi was Research Scientist...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 8yrs | no data | 1.11% ¥ 63.4m | |
| Chief Financial Officer & Director of Accounting and Corporate Planning | no data | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| GM of Corporate Planning Management Department & Director | no data | no data | no data | |
| GM of Pharmaceutical Development and Pharmaceutical Affairs Department & Director | 2yrs | no data | no data | |
| Director & GM of Quality Assurance Department | less than a year | no data | no data |
2.0yrs
Average Tenure
52yo
Average Age
Experienced Management: 4884's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 19yrs | no data | 1.11% ¥ 63.4m | |
| GM of Corporate Planning Management Department & Director | 3yrs | no data | no data | |
| GM of Pharmaceutical Development and Pharmaceutical Affairs Department & Director | 2yrs | no data | no data | |
| Director & GM of Quality Assurance Department | less than a year | no data | no data | |
| Independent Outside Director | 6yrs | no data | no data | |
| Part Time Director | 8yrs | no data | no data | |
| Audit & Supervisory Board Member | 6yrs | no data | no data | |
| Audit & Supervisory Board Member | 6yrs | no data | no data | |
| Audit & Supervisory Board Member | 6yrs | no data | no data | |
| Independent Outside Director | 4yrs | no data | no data |
6.0yrs
Average Tenure
52yo
Average Age
Experienced Board: 4884's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 18:32 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kringle Pharma, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyoichiro Shigemura | Nomura Securities Co. Ltd. |